https://www.selleckchem.com/products/cpi-203.html
evelopment and evaluation of interventions that support the contraceptive decisions and autonomy of individuals with medical conditions. To explore the effect on ovarian activity and ovulation of 28 days of correct daily use of a progestogen-only pill containing norgestrel 0.075 mg. We performed a prospective, randomized, crossover study at 2 US sites, recruiting healthy women of reproductive age to use norgestrel 0.075 mg daily for three 28-day treatment cycles. We monitored ovarian activity every 3 to 4 days with reproductive hormone
Aimer
Commentaire
Partagez
